APOBEC3G oligomerization is associated with the inhibition of both Alu and LINE-1 retrotransposition

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Koyama, Takayoshi ^a   Arias, Juan Fernando ^a   Iwabu, Yukie ^a   Yokoyama, Masaru ^a   Fujita, Hideaki ^b   Sato, Hironori ^a   Tokunaga, Kenzo ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NAGASAKI INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; DIMER; DNA;

AMINO TERMINAL SEQUENCE; ARTICLE; DNA TRANSPOSITION; GERM CELL; HUMAN; HUMAN GENOME; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; LONG INTERSPERSED REPEAT; MOLECULAR MODEL; NUCLEOTIDE SEQUENCE; OLIGOMERIZATION; OPEN READING FRAME; PROTEIN ANALYSIS; RETROPOSON; SOMATIC CELL; TRANSPOSON;

ALU ELEMENTS; CYTIDINE DEAMINASE; HEK293 CELLS; HELA CELLS; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MODELS, MOLECULAR; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY;

EID: 84893179888     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084228     Document Type: Article

References (83)

1. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC et al. (2001) Initial sequencing and analysis of the human genome. Nature 409: 860-921. doi:10.1038/35057062. PubMed: 11237011. (Pubitemid 32165345)
2. Hohjoh H, Singer MF (1996) Cytoplasmic ribonucleoprotein complexes containing human LINE-1 protein and RNA. EMBO J 15: 630-639. PubMed: 8599946. (Pubitemid 26044576)
3. Martin SL (1991) Ribonucleoprotein particles with LINE-1 RNA in mouse embryonal carcinoma cells. Mol Cell Biol 11: 4804-4807. PubMed: 1715025.
4. Cost GJ, Feng Q, Jacquier A, Boeke JD (2002) Human L1 element target-primed reverse transcription in vitro. EMBO J 21: 5899-5910. doi:10.1093/emboj/cdf592. PubMed: 12411507. (Pubitemid 35315287)
5. Dewannieux M, Esnault C, Heidmann T (2003) LINE-mediated retrotransposition of marked Alu sequences. Nat Genet 35: 41-48. doi:10.1038/ng1223. PubMed: 12897783. (Pubitemid 37048594)
6. Claverie-Martín F, Flores C, Antón-Gamero M, González-Acosta H, García-Nieto V (2005) The Alu insertion in the CLCN5 gene of a patient with Dent's disease leads to exon 11 skipping. J Hum Genet 50: 370-374. doi:10.1007/s10038-005-0265-5. PubMed: 16041495.
7. Li X, Scaringe WA, Hill KA, Roberts S, Mengos A et al. (2001) Frequency of recent retrotransposition events in the human factor IX gene. Hum Mutat 17: 511-519. doi:10.1002/humu.1134. PubMed: 11385709. (Pubitemid 32480086)
8. Meischl C, Boer M, Ahlin A, Roos D (2000) A new exon created by intronic insertion of a rearranged LINE-1 element as the cause of chronic granulomatous disease. Eur J Hum Genet 8: 697-703. doi:10.1038/sj.ejhg.5200523. PubMed: 10980575.
9. Oldridge M, Zackai EH, McDonald-McGinn DM, Iseki S, Morriss-Kay GM et al. (1999) De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. Am J Hum Genet 64: 446-461. doi:10.1086/302245. PubMed: 9973282. (Pubitemid 129500527)
10. Yoshida K, Nakamura A, Yazaki M, Ikeda S, Takeda S (1998) Insertional mutation by transposable element, L1, in the DMD gene results in X-linked dilated cardiomyopathy. Hum Mol Genet 7: 1129-1132. doi:10.1093/hmg/7.7.1129. PubMed: 9618170. (Pubitemid 28306877)
11. Narita N, Nishio H, Kitoh Y, Ishikawa Y, Ishikawa Y et al. (1993) Insertion of a 5′ truncated L1 element into the 3′ end of exon 44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular dystrophy. J Clin Invest 91: 1862-1867. doi:10.1172/JCI116402. PubMed: 8387534. (Pubitemid 23141452)
12. Wallace MR, Andersen LB, Saulino AM, Gregory PE, Glover TW et al. (1991) A de novo Alu insertion results in neurofibromatosis type 1. Nature 353: 864-866. doi:10.1038/353864a0. PubMed: 1719426. (Pubitemid 21912644)
13. Kazazian HH Jr., Wong C, Youssoufian H, Scott AF, Phillips DG et al. (1988) Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature 332: 164-166. doi:10.1038/332164a0. PubMed: 2831458. (Pubitemid 18083562)
14. Baillie JK, Barnett MW, Upton KR, Gerhardt DJ, Richmond TA et al. (2011) Somatic retrotransposition alters the genetic landscape of the human brain. Nature 479: 534-537. doi:10.1038/nature10531. PubMed: 22037309.
15. Coufal NG, Garcia-Perez JL, Peng GE, Yeo GW, Mu Y et al. (2009) L1 retrotransposition in human neural progenitor cells. Nature 460: 1127-1131. doi:10.1038/nature08248. PubMed: 19657334.
16. Economou-Pachnis A, Lohse MA, Furano AV, Tsichlis PN (1985) Insertion of long interspersed repeated elements at the Igh (immunoglobulin heavy chain) and Mlvi-2 (Moloney leukemia virus integration 2) loci of rats. Proc Natl Acad Sci U S A 82: 2857-2861. doi:10.1073/pnas.82.9.2857. PubMed: 2986141. (Pubitemid 15096577)
17. Morse B, Rotherg PG, South VJ, Spandorfer JM, Astrin SM (1988) Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma. Nature 333: 87-90. doi:10.1038/333087a0. PubMed: 2834650.
18. Miki Y, Nishisho I, Horii A, Miyoshi Y, Utsunomiya J et al. (1992) Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res 52: 643-645. PubMed: 1310068.
19. Shukla R, Upton Kyle R, Muñoz-Lopez M, Gerhardt Daniel J, Fisher Malcolm E et al. (2013) Endogenous Retrotransposition Activates Oncogenic Pathways in Hepatocellular Carcinoma. Cell 153: 101-111. doi:10.1016/j.cell. 2013.02.032. PubMed: 23540693.
20. Sheehy AM, Gaddis NC, Choi JD, Malim MH (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418: 646-650. doi:10.1038/nature00939. PubMed: 12167863.
21. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK et al. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell 113: 803-809. doi:10.1016/S0092-8674(03)00423-9. PubMed: 12809610. (Pubitemid 36724943)
22. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L et al. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424: 99-103. doi:10.1038/nature01709. PubMed: 12808466. (Pubitemid 36834849)
23. Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC et al. (2003) The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424: 94-98. doi:10.1038/nature01707. PubMed: 12808465. (Pubitemid 36834848)
24. Mariani R, Chen D, Schröfelbauer B, Navarro F, König R et al. (2003) Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114: 21-31. doi:10.1016/S0092-8674(03)00515-4. PubMed: 12859895. (Pubitemid 36859838)
25. Bogerd HP, Doehle BP, Wiegand HL, Cullen BR (2004) A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc Natl Acad Sci U S A 101: 3770-3774. doi:10.1073/pnas.0307713101. PubMed: 14999100. (Pubitemid 38381053)
26. Mangeat B, Turelli P, Liao S, Trono D (2004) A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action. J Biol Chem 279: 14481-14483. doi:10.1074/jbc.C400060200. PubMed: 14966139. (Pubitemid 38618833)
27. Schröfelbauer B, Chen D, Landau NR (2004) A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proc Natl Acad Sci U S A 101: 3927-3932. doi:10.1073/pnas. 0307132101. PubMed: 14978281. (Pubitemid 38381079)
28. Russell RA, Wiegand HL, Moore MD, Schäfer A, McClure MO et al. (2005) Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J Virol 79: 8724-8731. doi:10.1128/JVI.79.14.8724-8731.2005. PubMed: 15994766. (Pubitemid 40934783)
29. Delebecque F, Suspène R, Calattini S, Casartelli N, Saïb A et al. (2006) Restriction of foamy viruses by APOBEC cytidine deaminases. J Virol 80: 605-614. doi:10.1128/JVI.80.2.605-614.2006. PubMed: 16378963. (Pubitemid 43062873)
30. Sasada A, Takaori-Kondo A, Shirakawa K, Kobayashi M, Abudu A et al. (2005) APOBEC3G targets human T-cell leukemia virus type 1. Retrovirology 2: 32. doi:10.1186/1742-4690-2-S1-S32. PubMed: 15943885.
31. Kobayashi M, Takaori-Kondo A, Shindo K, Abudu A, Fukunaga K et al. (2004) APOBEC3G targets specific virus species. J Virol 78: 8238-8244. doi:10.1128/JVI.78.15.8238-8244.2004. PubMed: 15254195. (Pubitemid 38944307)
32. Okeoma CM, Lovsin N, Peterlin BM, Ross SR (2007) APOBEC3 inhibits mouse mammary tumour virus replication in vivo. Nature 445: 927-930. doi:10.1038/nature05540. PubMed: 17259974.
33. Esnault C, Heidmann O, Delebecque F, Dewannieux M, Ribet D et al. (2005) APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature 433: 430-433. doi:10.1038/nature03238. PubMed: 15674295. (Pubitemid 40203324)
34. Bulliard Y, Turelli P, Röhrig UF, Zoete V, Mangeat B et al. (2009) Functional analysis and structural modeling of human APOBEC3G reveal the role of evolutionarily conserved elements in the inhibition of human immunodeficiency virus type 1 infection and Alu transposition. J Virol 83: 12611-12621. doi:10.1128/JVI.01491-09. PubMed: 19776130.
35. Hulme AE, Bogerd HP, Cullen BR, Moran JV (2007) Selective inhibition of Alu retrotransposition by APOBEC3G. Gene 390: 199-205. doi:10.1016/j.gene.2006. 08.032. PubMed: 17079095. (Pubitemid 46241746)
36. Chiu YL, Witkowska HE, Hall SC, Santiago M, Soros VB et al. (2006) High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc Natl Acad Sci U S A 103: 15588-15593. doi:10.1073/pnas.0604524103. PubMed: 17030807. (Pubitemid 44625636)
37. Kinomoto M, Kanno T, Shimura M, Ishizaka Y, Kojima A et al. (2007) All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Res 35: 2955-2964. doi:10.1093/nar/gkm181. PubMed: 17439959. (Pubitemid 47073634)
38. Ikeda T, Abd El Galil KH, Tokunaga K, Maeda K, Sata T et al. (2011) Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons. Nucleic Acids Res 39: 5538-5554. doi:10.1093/nar/gkr124. PubMed: 21398638.
39. Khatua AK, Taylor HE, Hildreth JE, Popik W (2010) Inhibition of LINE-1 and Alu retrotransposition by exosomes encapsidating APOBEC3G and APOBEC3F. Virology 400: 68-75. doi:10.1016/j.virol.2010.01.021. PubMed: 20153011.
40. Niewiadomska AM, Tian C, Tan L, Wang T, Sarkis PTN et al. (2007) Differential Inhibition of Long Interspersed Element 1 by APOBEC3 Does Not Correlate with High-Molecular-Mass-Complex Formation or P-Body Association. J Virol 81: 9577-9583. doi:10.1128/JVI.02800-06. PubMed: 17582006. (Pubitemid 47311504)
41. Arias JF, Koyama T, Kinomoto M, Tokunaga K (2012) Retroelements versus APOBEC3 family members: No great escape from the magnificent seven. Front Microbiol 3: 275. PubMed: 22912627.
42. Turelli P, Mangeat B, Jost S, Vianin S, Trono D (2004) Inhibition of hepatitis B virus replication by APOBEC3G. Science 303: 1829. doi:10.1126/science.1092066. PubMed: 15031497. (Pubitemid 38374868)
43. Noguchi C, Ishino H, Tsuge M, Fujimoto Y, Imamura M et al. (2005) G to A hypermutation of hepatitis B virus. Hepatology 41: 626-633. doi:10.1002/hep. 20580. PubMed: 15726649. (Pubitemid 40289512)
44. OhAinle M, Kerns JA, Malik HS, Emerman M (2006) Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H. J Virol 80: 3853-3862. doi:10.1128/JVI.80.8.3853-3862.2006. PubMed: 16571802.
45. Sawyer SL, Emerman M, Malik HS (2004) Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol 2: E275. doi:10.1371/journal.pbio.0020275. PubMed: 15269786.
46. Schumann GG (2007) APOBEC3 proteins: major players in intracellular defence against LINE-1-mediated retrotransposition. Biochem Soc Trans 35: 637-642. doi:10.1042/BST0350637. PubMed: 17511669.
47. Stenglein MD, Harris RS (2006) APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. J Biol Chem 281: 16837-16841. doi:10.1074/jbc.M602367200. PubMed: 16648136.
48. Muckenfuss H, Hamdorf M, Held U, Perkovic M, Löwer J et al. (2006) APOBEC3 proteins inhibit human LINE-1 retrotransposition. J Biol Chem 281: 22161-22172. doi:10.1074/jbc.M601716200. PubMed: 16735504. (Pubitemid 44181920)
49. Bogerd HP, Wiegand HL, Hulme AE, Garcia-Perez JL, O'Shea KS et al. (2006) Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc Natl Acad Sci U S A 103: 8780-8785. doi:10.1073/pnas.0603313103. PubMed: 16728505. (Pubitemid 43878096)
50. Turelli P, Vianin S, Trono D (2004) The innate antiretroviral factor APOBEC3G does not affect human LINE-1 retrotransposition in a cell culture assay. J Biol Chem 279: 43371-43373. doi:10.1074/jbc.C400334200. PubMed: 15322092. (Pubitemid 39390633)
51. Tan L, Sarkis PT, Wang T, Tian C, Yu XF (2009) Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1. FASEB J 23: 279-287. doi:10.1096/fj.07-088781. PubMed: 18827027.
52. Gilbert N, Lutz-Prigge S, Moran JV (2002) Genomic deletions created upon LINE-1 retrotransposition. Cell 110: 315-325. doi:10.1016/S0092-8674(02)00828-0. PubMed: 12176319.
53. Wallace N, Wagstaff BJ, Deininger PL, Roy-Engel AM (2008) LINE-1 ORF1 protein enhances Alu SINE retrotransposition. Gene 419: 1-6. doi:10.1016/j.gene.2008.04.007. PubMed: 18534786.
54. Iwabu Y, Fujita H, Kinomoto M, Kaneko K, Ishizaka Y et al. (2009) HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes. J Biol Chem 284: 35060-35072. doi:10.1074/jbc.M109.058305. PubMed: 19837671.
55. Iwabu Y, Kinomoto M, Tatsumi M, Fujita H, Shimura M et al. (2010) Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes. J Biol Chem 285: 35350-35358. doi:10.1074/jbc.M110.173286. PubMed: 20833716.
56. Prochnow C, Bransteitter R, Klein MG, Goodman MF, Chen XS (2007) The APOBEC-2 crystal structure and functional implications for the deaminase AID. Nature 445: 447-451. doi:10.1038/nature05492. PubMed: 17187054. (Pubitemid 46160914)
57. Chen KM, Harjes E, Gross PJ, Fahmy A, Lu Y et al. (2008) Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G. Nature 452: 116-119. doi:10.1038/nature06638. PubMed: 18288108. (Pubitemid 351355093)
58. Lavens D, Peelman F, Van der Heyden J, Uyttendaele I, Catteeuw D et al. (2010) Definition of the interacting interfaces of Apobec3G and HIV-1 Vif using MAPPIT mutagenesis analysis. Nucleic Acids Res 38: 1902-1912. doi:10.1093/nar/gkp1154. PubMed: 20015971.
59. Huthoff H, Autore F, Gallois-Montbrun S, Fraternali F, Malim MH (2009) RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1. PLoS Pathog 5: e1000330. PubMed: 19266078.
60. Zhang K-L, Mangeat B, Ortiz M, Zoete V, Trono D et al. (2007) Model Structure of Human APOBEC3G. PLOS ONE 2: e378. doi:10.1371/journal.pone.0000378. PubMed: 17440614.
61. Shirakawa K, Takaori-Kondo A, Yokoyama M, Izumi T, Matsui M et al. (2008) Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. Nat Struct Mol Biol 15: 1184-1191. doi:10.1038/nsmb.1497. PubMed: 18836454.
62. Labute P (2008) The generalized Born/volume integral implicit solvent model: estimation of the free energy of hydration using London dispersion instead of atomic surface area. J Comput Chem 29: 1693-1698. doi:10.1002/jcc.20933. PubMed: 18307169.
63. Ponder JW, Case DA (2003) Force fields for protein simulations. Adv Protein Chem 66: 27-85. doi:10.1016/S0065-3233(03)66002-X. PubMed: 14631816. (Pubitemid 37392314)
64. Onufriev A, Bashford D, Case DA (2000) Modification of the Generalized Born Model Suitable for Macromolecules. Journal of Physical Chemistry B 104: 3712-3720. doi:10.1021/jp993855a.
65. Navarro F, Bollman B, Chen H, König R, Yu Q et al. (2005) Complementary function of the two catalytic domains of APOBEC3G. Virology 333: 374-386. doi:10.1016/j.virol.2005.01.011. PubMed: 15721369. (Pubitemid 40250119)
66. Newman EN, Holmes RK, Craig HM, Klein KC, Lingappa JR et al. (2005) Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr Biol 15: 166-170. doi:10.1016/j.cub.2004.12.068. PubMed: 15668174.
67. Shandilya SM, Nalam MN, Nalivaika EA, Gross PJ, Valesano JC et al. (2010) Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces. Structure 18: 28-38. doi:10.1016/j.str.2009.10.016. PubMed: 20152150.
68. Cho K-i, Kim D, Lee D (2009) A feature-based approach to modeling protein-protein interaction hot spots. Nucleic Acids Res 37: 2672-2687. doi:10.1093/nar/gkp132. PubMed: 19273533.
69. Iwatani Y, Chan DS, Wang F, Maynard KS, Sugiura W et al. (2007) Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res 35: 7096-7108. doi:10.1093/nar/gkm750. PubMed: 17942420.
70. Bach D, Peddi S, Mangeat B, Lakkaraju A, Strub K et al. (2008) Characterization of APOBEC3G binding to 7SL RNA. Retrovirology 5: 54. doi:10.1186/1742-4690-5-54. PubMed: 18597676.
71. Muotri AR, Marchetto MC, Coufal NG, Oefner R, Yeo G et al. (2010) L1 retrotransposition in neurons is modulated by MeCP2. Nature 468: 443-446. doi:10.1038/nature09544. PubMed: 21085180.
72. Muotri AR, Chu VT, Marchetto MCN, Deng W, Moran JV et al. (2005) Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature 435: 903-910. doi:10.1038/nature03663. PubMed: 15959507. (Pubitemid 40896309)
73. Tchénio T, Casella JF, Heidmann T (2000) Members of the SRY family regulate the human LINE retrotransposons. Nucleic Acids Res 28: 411-415. doi:10.1093/nar/28.2.411. PubMed: 10606637. (Pubitemid 30057978)
74. Yang N, Kazazian HH Jr. (2006) L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat Struct Mol Biol 13: 763-771. doi:10.1038/nsmb1141. PubMed: 16936727. (Pubitemid 44338769)
75. Belancio VP, Roy-Engel AM, Pochampally RR, Deininger P (2010) Somatic expression of LINE-1 elements in human tissues. Nucleic Acids Res 38: 3909-3922. doi:10.1093/nar/gkq132. PubMed: 20215437.
76. Gasior SL, Wakeman TP, Xu B, Deininger PL (2006) The human LINE-1 retrotransposon creates DNA double-strand breaks. J Mol Biol 357: 1383-1393. doi:10.1016/j.jmb.2006.01.089. PubMed: 16490214.
77. Zheng YH, Jeang KT, Tokunaga K (2012) Host restriction factors in retroviral infection: promises in virus-host interaction. Retrovirology 9: 112. doi:10.1186/1742-4690-9-S2-P112. PubMed: 23254112.
78. Wang X, Han Y, Dang Y, Fu W, Zhou T et al. (2010) Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication. J Biol Chem 285: 14346-14355. doi:10.1074/jbc.M110.109314. PubMed: 20215113.
79. Furtak V, Mulky A, Rawlings SA, Kozhaya L, Lee K et al. (2010) Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity. PLOS ONE 5: e9081. doi:10.1371/journal.pone.0009081. PubMed: 20140200.
80. Lu C, Luo Z, Jäger S, Krogan NJ, Peterlin BM (2012) Moloney leukemia virus type 10 inhibits reverse transcription and retrotransposition of intracisternal a particles. J Virol 86: 10517-10523. doi:10.1128/JVI.00868-12. PubMed: 22811528.
81. Goodier JL, Cheung LE, Kazazian HH Jr. (2012) MOV10 RNA helicase is a potent inhibitor of retrotransposition in cells. PLoS Genet 8: e1002941. PubMed: 23093941.
82. Arjan-Odedra S, Swanson CM, Sherer NM, Wolinsky SM, Malim MH (2012) Endogenous MOV10 inhibits the retrotransposition of endogenous retroelements but not the replication of exogenous retroviruses. Retrovirology 9: 53. doi:10.1186/1742-4690-9-53. PubMed: 22727223.
83. Gallois-Montbrun S, Kramer B, Swanson CM, Byers H, Lynham S et al. (2007) Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J Virol 81: 2165-2178. doi:10.1128/JVI.02287-06. PubMed: 17166910.